Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 5
2006 2
2007 8
2008 7
2009 2
2010 6
2011 6
2012 3
2013 7
2014 6
2015 15
2016 15
2017 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 26721658

82 results

Results by year

Filters applied: . Clear all
Page 1
Prevention of Cataract by Statins.
Kostis JB, Dobrzynski JM. Kostis JB, et al. Am J Cardiol. 2016 Apr 1;117(7):1196. doi: 10.1016/j.amjcard.2016.01.001. Epub 2016 Jan 12. Am J Cardiol. 2016. PMID: 26851145 No abstract available.
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R; SEAS Investigators. Rossebø AB, et al. N Engl J Med. 2008 Sep 25;359(13):1343-56. doi: 10.1056/NEJMoa0804602. Epub 2008 Sep 2. N Engl J Med. 2008. PMID: 18765433 Free article. Clinical Trial.
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White JA, Tershakovec AM, Blazing MA, Braunwald E. Bohula EA, et al. Circulation. 2015 Sep 29;132(13):1224-33. doi: 10.1161/CIRCULATIONAHA.115.018381. Epub 2015 Sep 1. Circulation. 2015. PMID: 26330412 Clinical Trial.
Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial.
Bays HE, Patel MD, Mavros P, Ramey DR, Tomassini JE, Tershakovec AM, Baxter CA. Bays HE, et al. J Clin Lipidol. 2017 Jul-Aug;11(4):929-937. doi: 10.1016/j.jacl.2017.04.121. Epub 2017 May 8. J Clin Lipidol. 2017. PMID: 28647412
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
Toth PP, Ballantyne CM, Davidson MH, Tomassini JE, Ramey DR, Neff D, Tershakovec AM, Hu XH, Tunceli K. Toth PP, et al. J Clin Lipidol. 2012 Mar-Apr;6(2):180-91. doi: 10.1016/j.jacl.2011.11.007. Epub 2011 Dec 7. J Clin Lipidol. 2012. PMID: 22385552
82 results